---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-244260"
form_type: "8-K"
ticker: "SRZN"
cik: "0001824893"
company_name: "Surrozen, Inc./DE"
filed_at: "2021-08-12T23:59:59+00:00"
generated_at: "2026-06-29T13:53:16.492466+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Surrozen completes SPAC merger; Nasdaq listing under SRZN/SRZNW on Aug 12

## Summary
- Business combination with Consonance-HFW Acquisition Corp. closed August 11, 2021.
- Common stock and warrants start trading on Nasdaq August 12 under SRZN and SRZNW.
- Transaction approved by Consonance-HFW shareholders on August 10 and Surrozen stockholders.
- Existing management, led by CEO Craig Parker, to continue leading the combined company.
- Surrozen focuses on Wnt pathway therapeutics for tissue repair and regeneration.

## SEC filing metadata
- accession: 0001193125-21-244260
- form_type: 8-K
- ticker: SRZN
- cik: 0001824893
- company_name: Surrozen, Inc./DE
- filed_at: 2021-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824893/000119312521244260/0001193125-21-244260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824893/000119312521244260/d148870d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-244260
- JSON: https://secwatch.observer/filing/0001193125-21-244260.json
- Plain text: https://secwatch.observer/filing/0001193125-21-244260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.